Targets epithelial-mesenchymal transition (EMT) through the Jak2/Stat3/Slug signaling pathway while promoting the expression of MMP-2 and MMP-9 to enhance tumor metastasis and invasion. The gene discussed is MMP9; the disease is neoplasm.